Calcitonin Gene-related Peptide Monoclonal Antibody for Preventive Treatment of Episodic Migraine: A Meta Analysis

Migraine is a highly prevalent neurological disorder, which may lead to disable and determine the daily activity of patients [1 –4]. Most migraineurs have episodic migraine, defined as headache happen on less than 15days per month according to the International Classification of Headache Disorders (ICHD-II) [5–9]. Preventive treatments, such as valproate, topiramate, propranolol, metoprolol and flunarizine, were effectiv e in episodic migraine [1–3,10]. But most migraineurs might withdraw from the preventive treatment because of the adverse events, caused by the current preventive treatment which were not developed specially for migraine [1–3,11].
Source: Clinical Neurology and Neurosurgery - Category: Neurosurgery Authors: Source Type: research